OTHERS SUNWAY REAL ESTATE INVESTMENT TRUST (“SUNREIT”) - PROPOSED ISSUANCE OF MEDIUM TERM NOTES PURSUANT TO A MEDIUM TERM NOTE PROGRAMME OF RM3.0 BILLION IN NOMINAL VALUE BY SUNREIT CAPITAL BERHAD (FORMERLY KNOWN AS NOBLE PIONEER SDN BHD) , A WHOLLY-OWNED SUBSIDIARY OF SUNREIT
SUNWAY REAL ESTATE INVESTMENT TRUST |
Type | Announcement | |||||||||||||||||||||
Subject | OTHERS | |||||||||||||||||||||
Description | SUNWAY REAL ESTATE INVESTMENT TRUST (“SUNREIT”) - PROPOSED ISSUANCE OF MEDIUM TERM NOTES PURSUANT TO A MEDIUM TERM NOTE PROGRAMME OF RM3.0 BILLION IN NOMINAL VALUE BY SUNREIT CAPITAL BERHAD (FORMERLY KNOWN AS NOBLE PIONEER SDN BHD) , A WHOLLY-OWNED SUBSIDIARY OF SUNREIT | |||||||||||||||||||||
1. Introduction
HSBC Bank Malaysia Berhad, Maybank Investment Bank Berhad and RHB Investment Bank Berhad are the Joint Principal Advisers and Joint Lead Arrangers for the establishment of the MTN Programme. 2. Tenure, Rating and Purpose of the MTN Programme
The MTNs may be issued via direct/private placement, bought deal basis or book running basis, all without prospectus. The proceeds of the MTNs shall be utilised by the Issuer for the purpose of advancing to SUNREIT where the REIT Trustee shall utilise such proceeds for financing (including repayment of cash utilised by SUNREIT to part finance) the investment activities (including capital expenditure and the related acquisition and financing expenses) of SUNREIT and/or refinancing of existing/future borrowings undertaken by SUNREIT for its investment activities (including capital expenditure and the related acquisition and financing expenses) and/or working capital requirements of SUNREIT and to defray expenses incurred in relation to the MTN Programme as well as to refinance maturing MTNs on their respective maturity dates subsequent to the first issuance of the MTNs. This announcement is dated 14 October 2011. |
Announcement Info
Company Name | SUNWAY REAL ESTATE INVESTMENT TRUST |
Stock Name | SUNREIT |
Date Announced | 14 Oct 2011 |
Category | General Announcement |
Reference No | SR-111014-3D327 |